The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +21.67% increase from the last price of 21.78.
The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.00
Reporting Date Nov 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.